OCI N.V. Reports Full Year 2022 Adjusted Net Profit of $1.3 Billion Read more about OCI N.V. Reports Full Year 2022 Adjusted Net Profit of $1.3 Billion
Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma Read more about Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma
MDxHealth Announces UnitedHealthcare to Provide Commercial Coverage for the Genomic Prostate Score (GPS) Test Read more about MDxHealth Announces UnitedHealthcare to Provide Commercial Coverage for the Genomic Prostate Score (GPS) Test
Banco Comercial Português, S.A. informs about signing of conditional agreement concerning the sale of Millennium Financial Services sp. z o.o. and strategic insurance cooperation Read more about Banco Comercial Português, S.A. informs about signing of conditional agreement concerning the sale of Millennium Financial Services sp. z o.o. and strategic insurance cooperation
Airthings ASA: Successful completion of private placement Read more about Airthings ASA: Successful completion of private placement
Nordea Bank Abp: Repurchase of own shares on 13.02.2023 Read more about Nordea Bank Abp: Repurchase of own shares on 13.02.2023
Sparebanken Sogn og Fjordane interim report Q4 2022 Read more about Sparebanken Sogn og Fjordane interim report Q4 2022
Publicis Groupe: Notification of Share Repurchase Transactions Read more about Publicis Groupe: Notification of Share Repurchase Transactions
EssilorLuxottica: Full-Year 2022 Results Conference Call Invitation - CORRECT Read more about EssilorLuxottica: Full-Year 2022 Results Conference Call Invitation - CORRECT